NCT00855517 A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma Status WITHDRAWN Phase PHASE2
NCT00847483 Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US Status COMPLETED Phase PHASE4
NCT00846989 Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT00845299 Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma Status COMPLETED Phase PHASE2
NCT00834171 A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin Status COMPLETED Phase N/A
NCT00825396 An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension Status COMPLETED Phase NA
NCT00823043 A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs Status COMPLETED Phase N/A
NCT00822081 Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT00822055 Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT00821002 A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) Status COMPLETED Phase PHASE2
NCT00820300 A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma Status COMPLETED Phase PHASE2
NCT00815373 The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) Status WITHDRAWN Phase NA
NCT00811564 An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects Status COMPLETED Phase PHASE4
NCT00809848 Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma Status COMPLETED Phase PHASE1/PHASE2
NCT00804648 Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT00804115 The International Collaborative Exfoliation Syndrome Treatment Study Status UNKNOWN Phase NA